InvestorsHub Logo
Followers 224
Posts 31832
Boards Moderated 4
Alias Born 10/10/2005

Re: McMagyar post# 601

Monday, 04/18/2022 12:25:38 PM

Monday, April 18, 2022 12:25:38 PM

Post# of 625
Biogen (NASDAQ:BIIB) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $265.00 price target on the stock, up previously from $235.00.This represents a 23.7% upside from the current price of $214.28

---- Biotechs are due for a run soon....jmo

Successful Trading is the art of minimizing long term risk and maximizing capital allocation.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BIIB News